CIK 0001982708 · Non-accelerated filer<br>Emerging growth company
Anbio Biotechnology
Sign in to watch- Ticker
- NNNN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 4916096247281
- Business address
- FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, Germany, 60308
- 424B4 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
Page 1 of 1 · 7 filings